MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
-0.55%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$659M
AUM Growth
+$659M
(-0.88%)
Cap. Flow
-$36.2M
Cap. Flow
% of AUM
-5.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
4
Closed
–
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$86.7M |
| 2 |
Celldex Therapeutics
CLDX
|
$1.47M |
Top Sells
| 1 |
Exelixis
EXEL
|
$68.2M |
| 2 |
ProShares UltraShort S&P500
SDS
|
$44.1M |
| 3 |
iShares MSCI India ETF
INDA
|
$6.24M |
| 4 |
WisdomTree India Earnings Fund ETF
EPI
|
$5.79M |
Sector Composition
| 1 | Healthcare | 92.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $422M | 64.06% | 17,416,738 -2,812,975 | -14% | -$68.2M |
|
|
2
Esperion Therapeutics
ESPR
$448M
| $115M | 17.46% | 2,294,935 +1,728,935 | +305% | +$86.7M |
|
3
Alkermes
ALKS
$4.78B
| $52.4M | 7.95% | 1,030,639 | – | – |
|
|
4
Celldex Therapeutics
CLDX
$1.47B
| $18.1M | 2.74% | 6,312,700 +512,700 | +9% | +$1.47M |
|
5
ProShares UltraPro Short S&P 500
SPXU
$527M
| $17M | 2.58% | 1,230,000 | – | – |
|
|
6
ProShares UltraShort S&P500
SDS
$445M
| $14.7M | 2.23% | 315,000 -945,000 | -75% | -$44.1M |
|
|
7
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $10.1M | 1.53% | 400,000 -230,000 | -37% | -$5.79M |
|
|
8
iShares MSCI India ETF
INDA
$9.17B
| $9.53M | 1.45% | 290,000 -190,000 | -40% | -$6.24M |
|